TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04866277

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fast-track referral for reference services
Description: Activation of fast-track referral for specialized units and care programs for the four psychosocial and behavioural risk factors under study.
Study: NCT06058221

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: simultaneous videolaryngoscopy
Description: Two specialists perform tracheal intubation, one using a video laryngoscope to expose the vocal cords and the other using a fiberoptic bronchoscope.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: supraglottic airway
Description: After inserting the supraglottic airway, the specialist performs intubation using a fiberoptic bronchoscope through the supraglottic airway.
Study: NCT06304935

Intervention type: OTHER
Group type: OTHER
Intervention: Use of injectable platelet rich fibrin after tonsillectomy by injection of IPRF in one tonsillar bed and use of other side as control
Description: Compare both sides of tonsillar beds in post operative healing, pain and hemostasis
Study: NCT05124340

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCG vial vaccine
Description: Intradermal injection

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: BCG ampoule vaccine
Description: Intradermal injection
Study: NCT06051981

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride
Description: a flavored xylitol-sweetened, 5% sodium fluoride in a resin carrier delivered in a 1.2 ml syringe or in a 0.4 ml unit, Ultradent, USA) will be applied on all teeth according to the manufacturer's instructions.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intensive 5% sodium fluoride
Description: Intensive FV will be applied three times a week for a week (every two days).
Study: NCT05973162

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual Realty Training
Description: They would be receiving treatment as follow:~Virtual Reality is a technology that aims to completely immerse the user inside the computer generated world, giving the impression to the user that they have stepped inside the synthetic world. RA mobile phone , head mounted display (HMD) will be used and videos of patient's interest will be played on phone which will create a 3D world around the patient.~And while watching conventional physical therapy will be performed side by side.~Conventional PT including range of motion exercises of elbow region including flexion, extension, supination, pronation, stretching and strengthening exercises of elbow muscles. Frequency: 10 reps with 5 sec hold for 3 times/week for 2 weeks Intensity: moderate-high intensity (depending on pain tolerance) Time: 10 mins Type: Strengthening Exercises

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transverse friction massage (TFM)
Description: They would be receiving treatment as follow:~Transverse friction massage (Soft tissue mobilization technique) on the surrounding burn region for 5-10min in intervals. Frequency: 3 times/week for 2 consecutive weeks. Intensity: moderate intensity (pain free) Time: 10 mins Conventional PT including range of motion exercises of elbow region including flexion, extension, supination, pronation, stretching and strengthening exercises of elbow muscles. Frequency: 10 reps with 5 sec hold for 3 times/week for 2 weeks Intensity: moderate-high intensity (depending on pain tolerance) Time: 10 mins Type: Strengthening Exercises
Study: NCT06635551

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasonographic evaluation of vascular catheter-related thrombosis after oncological surgery.
Description: In patients who will undergo oncological surgery and have a central venous catheter, the presence of thrombosis, its duration of occurrence and its dimensions will be evaluated by ultrasonography.

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasonographic evaluation of vascular catheter-related thrombosis after non-oncological surgery.
Description: In patients who will undergo non-oncological surgery and have a central venous catheter, the presence of thrombosis, its duration of occurrence and its dimensions will be evaluated by ultrasonography.
Study: NCT05962229

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (S)-Nicotine
Description: Participants will spend 8 hours in the hospital research ward and will vape e-liquid containing 100% (S)-nicotine. They will vape following a standardized session, followed by a 4 hour abstinence period. Participants will then vape as they wish (ad libitum) for 90 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (S)-Nicotine
Description: Participants will spend 8 hours in the hospital research ward and will vape e-liquid containing 100% (S)-nicotine. They will vape following a standardized session, followed by a 4 hour abstinence period. Participants will then vape as they wish (ad libitum) for 90 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (S)-Nicotine
Description: Participants will spend 8 hours in the hospital research ward and will vape e-liquid containing 100% (S)-nicotine. They will vape following a standardized session, followed by a 4 hour abstinence period. Participants will then vape as they wish (ad libitum) for 90 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (R)- nicotine
Description: Participants will spend 8 hours in the hospital research ward and will vape e-liquid containing 100% (R)-nicotine. They will vape following a standardized session, followed by a 4 hour abstinence period. Participants will then vape as they wish (ad libitum) for 90 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (R)- nicotine
Description: Participants will spend 8 hours in the hospital research ward and will vape e-liquid containing 100% (R)-nicotine. They will vape following a standardized session, followed by a 4 hour abstinence period. Participants will then vape as they wish (ad libitum) for 90 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (R)- nicotine
Description: Participants will spend 8 hours in the hospital research ward and will vape e-liquid containing 100% (R)-nicotine. They will vape following a standardized session, followed by a 4 hour abstinence period. Participants will then vape as they wish (ad libitum) for 90 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Racemic nicotine
Description: Participants will spend 8 hours in the hospital research ward and will vape e-liquid containing 50% (R)-nicotine and 50% (S)-nicotine. They will vape following a standardized session, followed by a 4 hour abstinence period. Participants will then vape as they wish (ad libitum) for 90 minutes.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Racemic nicotine
Description: Participants will spend 8 hours in the hospital research ward and will vape e-liquid containing 50% (R)-nicotine and 50% (S)-nicotine. They will vape following a standardized session, followed by a 4 hour abstinence period. Participants will then vape as they wish (ad libitum) for 90 minutes.
Study: NCT06051981

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Casein Phosphopeptide-Amorphous Calcium Phosphate
Description: for 12 weeks. A thin layer from Tooth Mousse™ will be applied to the teeth after daily brushing with traditional toothpaste and left intact for 180 seconds before rinsing with distilled water

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Resin infiltration
Description: resin infiltration will be applied as specified by the manufacturer.
Study: NCT06446011

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: root canal treatment in Ckd patients
Description: root canal treatment in teeth with apical periodontitis to observe periapical healing , and change in eGFR ,blood urea and creatinine and HSCRP

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: root canal treatment in healthy patients
Description: root canal treatment in teeth with apical periodontitis to observe periapical healing and change in HSCRP
Study: NCT06079957

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ergonomic training
Description: 1. Individuals will be given a copy of ergonomic guidelines to follow which includes:~* Organize workstation according to the primary , secondary and tertiary zones.~* Place frequently used items within the reach of an arm.~* Don't move head while reading documents instead raise or lower the eyes to read.~* Correct the monitor height such that the top of the screen is at or slightly lower than eye level.~* Keep reference material upright at desk.~* Avoid slouched postural habits, sit upright.~* Adjust chair height in such a way that it shouldn't compress the thigh.~* Arm rest should be at elbow flexion of 90 degrees.~* Phone must be cradled between neck and shoulder to avoid forward head posture.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ergonomic training
Description: 1. Individuals will be given a copy of ergonomic guidelines to follow which includes:~* Organize workstation according to the primary , secondary and tertiary zones.~* Place frequently used items within the reach of an arm.~* Don't move head while reading documents instead raise or lower the eyes to read.~* Correct the monitor height such that the top of the screen is at or slightly lower than eye level.~* Keep reference material upright at desk.~* Avoid slouched postural habits, sit upright.~* Adjust chair height in such a way that it shouldn't compress the thigh.~* Arm rest should be at elbow flexion of 90 degrees.~* Phone must be cradled between neck and shoulder to avoid forward head posture.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Neck Exercises
Description: Neck Exercises Strengthening exercises of Deep cervical flexors,rhomboids,lower Trapezius, Middle Trapezius, serratus anterior.~Neck Stretching of Suboccipitals,Sternocleidomastoid ,Scalenes,Upper trapezius, Levator scapulae,Pectoralis major and minor.
Study: NCT05962229

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Racemic nicotine
Description: Participants will spend 8 hours in the hospital research ward and will vape e-liquid containing 50% (R)-nicotine and 50% (S)-nicotine. They will vape following a standardized session, followed by a 4 hour abstinence period. Participants will then vape as they wish (ad libitum) for 90 minutes.
Study: NCT05392816

Intervention type: OTHER
Group type: OTHER
Intervention: Single meal non-heme iron absorption
Description: Two study groups, each designed as cross-over single-blinded iron isotope trials in apparent healthy Swedish women of the ages 18-45 years. Each participant serves as their own control. Meals are tagged with radiolabeled non-heme iron 55Fe and 59Fe.

Intervention type: OTHER
Group type: OTHER
Intervention: Single meal non-heme iron absorption
Description: Two study groups, each designed as cross-over single-blinded iron isotope trials in apparent healthy Swedish women of the ages 18-45 years. Each participant serves as their own control. Meals are tagged with radiolabeled non-heme iron 55Fe and 59Fe.
Study: NCT05081362

Intervention type: OTHER
Group type: OTHER
Intervention: Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity
Description: Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity during ten minutes in rest and ten minutes in orthostatic position

Intervention type: OTHER
Group type: OTHER
Intervention: Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity
Description: Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity during ten minutes in rest and ten minutes in orthostatic position

Intervention type: OTHER
Group type: OTHER
Intervention: Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity
Description: Non invasive cardiovascular monitoring with CNAP device of arterial pressure, ECG and respiratory activity during ten minutes in rest and ten minutes in orthostatic position
Study: NCT05267847

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Description: local anesthetic injection with articaine 4% 1:100,000 epinephrine then an application ice packs

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional local anesthesia
Description: local anesthetic injection with articaine 4% 1:100,000 epinephrine
Study: NCT04600752

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Augmentin (ES)-600
Description: Augmentin ES will be administered as reconstituted oral suspension containing Amoxicillin and Potassium Clavulanate 600 mg/42.9 mg per 5 milliliters.
Study: NCT04970355

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Erenumab
Description: Pre-filled syringe; s.c. injection

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pre-filled syring; s.c. injection
Study: NCT05799586

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine health preservation group
Description: The traditional Chinese medicine health preservation intervention for depression was developed based on a previous systematic review and meta-analysis of Traditional Chinese medicine based integrated health interventions for depression, traditional Chinese medicine health preservation textbooks, clinical practice guidelines related to traditional Chinese medicine health preservation and traditional Chinese medicine treatment for depression. The content and structure of traditional Chinese medicine health preservation for depression was achieved among Hong Kong traditional Chinese medicine experts via a Delphi study.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Waitlist control group
Description: Usual care
Study: NCT03057678

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Testing of Pre-Positioning Frame
Description: Placement of bone screws, CT scanning, Surgical planning, Robot motion planning
Study: NCT04693988

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Case Management
Description: a case manager is available by phone to assist patient with attending cardiac rehabilitation sessions as well as provide advice about cardiac symptoms and behavioral life style changes
Study: NCT04709107

Intervention type: OTHER
Intervention: Quality of life assessment - elective
Description: Patients will be asked to fill up both VascuQoL-6 and SF-36 questionnaires before the procedure, as well at 30-days and 1-year follow-up visit while they are sitting in the waiting room. To assess reliability and systematic shift and variation between the two assessments, elective patients will be asked to fill the VascuQoL-6 again at the admission to hospital, as well as 1 week after the 30-days follow-up vie an e-mail link for a test-retest assessment. All questionnaires will be administered on a tablet.~During the 30-days follow-up 4 extra questions concerning patient related outcomes and occurrence of major complication will be added to the VascuQoL-6 questionnaire in the App. During every visit (preoperatively, at 30-days and 1-year follow-up) the stage of the lower limb peripheral artery disease will be noted according to the WIfI-Classification.

Intervention type: OTHER
Intervention: Quality of life assessment - emergent
Description: Patients will be asked to fill up both VascuQoL-6 and SF-36 questionnaires before the procedure, as well at 30-days and 1-year follow-up visit while they are sitting in the waiting room. All questionnaires will be administered on a tablet.~During the 30-days follow-up 4 extra questions concerning patient related outcomes and occurrence of major complication will be added to the VascuQoL-6 questionnaire in the App. During every visit (preoperatively, at 30-days and 1-year follow-up) the stage of the lower limb peripheral artery disease will be noted according to the WIfI-Classification.
Study: NCT05796687

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: My Future Self
Description: My Future Self is based upon the Theory of Possible Selves, which promotes the capacity of young people to construct goals for a successful adulthood. Youth who hold a balanced set of negative and positive images of their future have both a) a positive goal to strive for and b) awareness of the personally relevant consequences of not meeting that goal. My Future Self also includes two new supportive gaming elements that reinforce learning of relevant knowledge and skills as well as provide opportunities for youth to individually practice these skills in a personalized virtual environment. Gaming interventions using interactive technology can significantly increase self-reported abstinence and lower reports of diagnosed STD in young women, as well as reduce risky sex in high-risk young men who have sex with men. Youth will participate in these gaming elements on tablets provided by CHLA. My Future Self will be implemented as a ninety-minute small group 5-week program.
Study: NCT01245725

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tirofiban (Aggrastat)
Description: Tirofiban (Aggrastat) will be dosed as a 25mcg/kg i.v. bolus followed by a 0.15mcg/kg/min i.v. infusion during a percutaneous coronary intervention plus two hours after the procedure.~Patients will receive tirofiban (Aggrastat) on a background of oral anti-platelet agent(s) and either unfractionated heparin (50U/kg and repeat dosing guided per guidelines) or bivalirudin as per local practice and physician discretion.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be dosed as an i.v. bolus followed by an i.v. infusion during a percutaneous coronary intervention plus two hours after the procedure.~Patients will receive placebo on a background of oral anti-platelet agent(s) and either unfractionated heparin (50U/kg and repeat dosing guided per guidelines) or bivalirudin as per local practice and physician discretion.
Study: NCT05362994

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Selution SLR™ sirolimus-eluting balloon
Description: If the residual stenosis is ≤30% after initial plain old balloon angioplasty, the investigators will perform angioplasty with the Selution SLR catheter, inflated at nominal pressure for at least 120 seconds. After dilatation of the entire target-lesion, biplane angiograms and IVUS imaging will be obtained. Technical success is defined as residual diameter stenosis ≤30% and adequate distal run-off. Bail-out stenting will be performed if residual stenosis is \>30%, either after plain old balloon angioplasty or angioplasty with Selution SLR. For lesions with residual stenosis \>30% but not suitable for stenting, repeat angioplasty will be performed for at most twice.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Plain old balloon angioplasty
Description: The investigators routinely start with a balloon catheter with a diameter ≥0.5 mm smaller than the reference vessel and ended with a balloon catheter with the size approximately equal to the reference vessel diameter. Three minutes after balloon predilation, the investigators will obtain an angiogram. If the residual stenosis is ≤30%, no further intervention will be performed in the plain old balloon (POB) group.
Study: NCT05268757

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Oral hygiene discontinuation
Description: Oral hygiene discontinuation for 14 days followed by 14 days of regular oral care

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Oral hygiene discontinuation
Description: Oral hygiene discontinuation for 14 days followed by 14 days of regular oral care
Study: NCT04832347

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Exercise Group will be given stabilization exercises for a total of 24 sessions, 3 times a week for 8 weeks, each session for 45 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vagus Nerve Stimulation
Description: Vagus therapy will be applied for 8 weeks, 3 times a week for a total of 24 sessions, each session for 30 minutes.
Study: NCT06054399

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: educational program
Description: Education resources in Spanish through social media directed to the targeted audience mentioned above. There will be at least three interventions along the study, one for each pregnancy trimester, including topics such as: Migraine criteria, management strategies, risks of medication overuse, alarm symptoms, etc. These educational interventions will be conducted by trained health care professionals, mainly using audio-visual media.
Study: NCT04589455

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hennep extract
Description: Hennep extract from Becanex containing 70 mg CBD

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Hennep extract
Description: Hennep extract from Becanex containing 70 mg CBD
Study: NCT05186766

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Video-Assisted Operating Room Introduce Program
Description: Video demonstration about operation room
Study: NCT04922697

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Intervention
Description: Watch educational videos and use wearable air pollution sensor

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Complete questionnaires
Study: NCT06174207

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oxygen
Description: Standard supplemental Oxygen therapy (5l/min) will be applied with an oxygen concentrator via nasal cannula.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Oxygen
Description: Standard supplemental Oxygen therapy (5l/min) will be applied with an oxygen concentrator via nasal cannula.
Study: NCT05314712

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Sleep intervention
Description: Participants will receive a 9-week sleep intervention through text and Facebook that include traditional Blackfoot cultural components combined with scientifically validated strategies for sleep.
Study: NCT04622969

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Child Development Program
Description: The Healthy Child Development Program is a family-based intervention focused on strengthening positive behaviors in children, managing misbehavior, and addressing healthy lifestyle choices.
Study: NCT05129995

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Passive heat treatment
Description: Participants will be subjected to an 8-week (3 x pw) passive heat treatment, by means of infrared sauna bathing, intervention.
Study: NCT03260972

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chloroprocaine Hcl 2% Inj
Description: 20 mls of Chloroprocaine Hcl 2% Inj (1 vial containing 400mg/20 mls of chloroprocaine) will be instilled into the abdomen prior to fascia closure.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: 20 mls of normal saline will be instilled into the abdomen prior to fascia closure.